Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa.
Nour
May
M
Cell Biology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Oklahoma City, OK 73104, USA.
Fliesler
Steven J
SJ
Naash
Muna I
MI
D019943:Amino Acid Substitution; D000818:Animals; D004195:Disease Models, Animal; D004596:Electroretinography; D018698:Glutamic Acid / Q000378:metabolism; D007381:Intermediate Filament Proteins / Q000235:genetics* / Q000378:metabolism* / Q000648:ultrastructure; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000378:metabolism* / Q000648:ultrastructure; D051379:Mice; D008822:Mice, Transgenic; D009419:Nerve Tissue Proteins / Q000235:genetics* / Q000378:metabolism* / Q000648:ultrastructure; D064531:Peripherins; D010641:Phenotype; D017949:Retinal Cone Photoreceptor Cells / Q000502:physiology; D017948:Retinal Rod Photoreceptor Cells / Q000502:physiology; D012174:Retinitis Pigmentosa / Q000235:genetics* / Q000503:physiopathology
D007381:Intermediate Filament Proteins; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D064531:Peripherins; C578996:Prph2 protein, mouse; D018698:Glutamic Acid